Annual SGA
$25.20 M
-$3.90 M-13.40%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual SGA is $25.20 million, with the most recent change of -$3.90 million (-13.40%) on December 31, 2023.
- During the last 3 years, EIGR annual SGA has risen by +$4.64 million (+22.59%).
- EIGR annual SGA is now -13.40% below its all-time high of $29.11 million, reached on December 31, 2022.
Performance
EIGR SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$4.70 M
-$752.00 K-13.79%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly SGA is $4.70 million, with the most recent change of -$752.00 thousand (-13.79%) on December 31, 2023.
- Over the past year, EIGR quarterly SGA has dropped by -$3.60 million (-43.36%).
- EIGR quarterly SGA is now -50.58% below its all-time high of $9.52 million, reached on March 31, 2023.
Performance
EIGR Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.95 B
-$74.96 M-3.99%
December 31, 2023
Summary
- As of February 12, 2025, EIGR TTM SGA is -$1.95 billion, with the most recent change of -$74.96 million (-3.99%) on December 31, 2023.
- Over the past year, EIGR TTM SGA has dropped by -$1.98 billion (-6805.06%).
- EIGR TTM SGA is now -1833.07% below its all-time high of -$100.95 million.
Performance
EIGR TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
EIGR Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -13.4% | -43.4% | -6805.1% |
3 y3 years | +22.6% | -13.2% | -9592.2% |
5 y5 years | +80.6% | +15.2% | -10000.0% |
EIGR Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -13.4% | +5.5% | -50.6% | at low | -58.3% | at low |
5 y | 5-year | -13.4% | +47.3% | -50.6% | +2.6% | -126.8% | at low |
alltime | all time | -13.4% | +2639.6% | -50.6% | +179.0% | -1833.1% | at low |
Eiger BioPharmaceuticals Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | $25.20 M(-13.4%) | $4.70 M(-13.8%) | $25.20 M(-12.5%) |
Sep 2023 | - | $5.45 M(-1.4%) | $28.80 M(-5.0%) |
Jun 2023 | - | $5.53 M(-41.8%) | $30.31 M(-4.7%) |
Mar 2023 | - | $9.52 M(+14.6%) | $31.81 M(+9.3%) |
Dec 2022 | $29.11 M(+21.8%) | $8.30 M(+19.2%) | $29.11 M(+8.6%) |
Sep 2022 | - | $6.96 M(-0.9%) | $26.79 M(+1.9%) |
Jun 2022 | - | $7.03 M(+3.1%) | $26.29 M(+4.5%) |
Mar 2022 | - | $6.81 M(+13.9%) | $25.15 M(+5.2%) |
Dec 2021 | $23.90 M(+16.3%) | $5.98 M(-7.5%) | $23.90 M(+2.4%) |
Sep 2021 | - | $6.47 M(+9.9%) | $23.33 M(+6.6%) |
Jun 2021 | - | $5.89 M(+5.8%) | $21.89 M(+4.9%) |
Mar 2021 | - | $5.56 M(+2.7%) | $20.88 M(+1.6%) |
Dec 2020 | $20.56 M(+20.1%) | $5.42 M(+7.8%) | $20.56 M(+4.2%) |
Sep 2020 | - | $5.03 M(+3.2%) | $19.73 M(+4.1%) |
Jun 2020 | - | $4.87 M(-7.0%) | $18.95 M(+3.5%) |
Mar 2020 | - | $5.24 M(+14.3%) | $18.30 M(+6.9%) |
Dec 2019 | $17.11 M(+22.6%) | $4.58 M(+7.9%) | $17.11 M(+3.0%) |
Sep 2019 | - | $4.25 M(+0.5%) | $16.61 M(+3.8%) |
Jun 2019 | - | $4.22 M(+4.1%) | $16.01 M(+6.6%) |
Mar 2019 | - | $4.06 M(-0.6%) | $15.02 M(+7.6%) |
Dec 2018 | $13.96 M | $4.08 M(+12.1%) | $13.96 M(+10.1%) |
Sep 2018 | - | $3.64 M(+12.5%) | $12.68 M(+7.8%) |
Jun 2018 | - | $3.24 M(+8.1%) | $11.76 M(+2.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2018 | - | $2.99 M(+6.7%) | $11.47 M(-4.4%) |
Dec 2017 | $12.00 M(-8.4%) | $2.81 M(+2.9%) | $12.00 M(-5.7%) |
Sep 2017 | - | $2.73 M(-7.4%) | $12.73 M(-4.0%) |
Jun 2017 | - | $2.95 M(-16.4%) | $13.26 M(+3.7%) |
Mar 2017 | - | $3.52 M(-0.3%) | $12.79 M(-2.4%) |
Dec 2016 | $13.11 M(+169.9%) | $3.53 M(+8.2%) | $13.11 M(+261.6%) |
Sep 2016 | - | $3.26 M(+31.8%) | $3.62 M(+25.3%) |
Jun 2016 | - | $2.48 M(-35.4%) | $2.89 M(-26.0%) |
Mar 2016 | - | $3.83 M(-164.4%) | $3.91 M(-19.5%) |
Dec 2015 | $4.86 M(-53.1%) | -$5.95 M(-334.9%) | $4.86 M(-66.8%) |
Sep 2015 | - | $2.53 M(-27.5%) | $14.60 M(-1.9%) |
Jun 2015 | - | $3.49 M(-26.9%) | $14.88 M(+11.0%) |
Mar 2015 | - | $4.78 M(+25.9%) | $13.41 M(+29.7%) |
Dec 2014 | $10.34 M(+240.5%) | $3.80 M(+34.9%) | $10.34 M(+41.6%) |
Sep 2014 | - | $2.81 M(+39.1%) | $7.30 M(+34.3%) |
Jun 2014 | - | $2.02 M(+18.6%) | $5.44 M(+29.8%) |
Mar 2014 | - | $1.71 M(+125.4%) | $4.19 M(+38.0%) |
Dec 2013 | $3.04 M(+15.4%) | $757.00 K(-20.5%) | $3.04 M(+33.2%) |
Sep 2013 | - | $952.00 K(+22.8%) | $2.28 M(+71.7%) |
Jun 2013 | - | $775.00 K(+40.1%) | $1.33 M(+140.1%) |
Mar 2013 | - | $553.00 K | $553.00 K |
Dec 2012 | $2.63 M(+186.0%) | - | - |
Dec 2011 | $920.00 K(-49.8%) | - | - |
Jun 2011 | $1.83 M | - | - |
FAQ
- What is Eiger BioPharmaceuticals annual SGA?
- What is the all time high annual SGA for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual SGA year-on-year change?
- What is Eiger BioPharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly SGA year-on-year change?
- What is Eiger BioPharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals TTM SGA year-on-year change?
What is Eiger BioPharmaceuticals annual SGA?
The current annual SGA of EIGR is $25.20 M
What is the all time high annual SGA for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual SGA is $29.11 M
What is Eiger BioPharmaceuticals annual SGA year-on-year change?
Over the past year, EIGR annual SGA has changed by -$3.90 M (-13.40%)
What is Eiger BioPharmaceuticals quarterly SGA?
The current quarterly SGA of EIGR is $4.70 M
What is the all time high quarterly SGA for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly SGA is $9.52 M
What is Eiger BioPharmaceuticals quarterly SGA year-on-year change?
Over the past year, EIGR quarterly SGA has changed by -$3.60 M (-43.36%)
What is Eiger BioPharmaceuticals TTM SGA?
The current TTM SGA of EIGR is -$1.95 B
What is the all time high TTM SGA for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high TTM SGA is -$100.95 M
What is Eiger BioPharmaceuticals TTM SGA year-on-year change?
Over the past year, EIGR TTM SGA has changed by -$1.98 B (-6805.06%)